Neurocrine Biosciences (NBIX) Tops Q2 EPS by 50c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $155.64 --0%
Revenue Growth %: +30.8%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +30.8%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of $1.63, $0.50 better than the analyst estimate of $1.13. Revenue for the quarter came in at $580 million versus the consensus estimate of $547.1 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- GrafTech raises graphite electrode prices by at least 30%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
